Melanocortin-1 receptor (MC1R) genotypes do not correlate with size in two cohorts of medium-to-giant congenital melanocytic nevi

dc.contributor.authorCalbet Llopart, Neus
dc.contributor.authorPascini Garrigòs, Mireia
dc.contributor.authorTell Martí, Gemma
dc.contributor.authorPotrony Mateu, Míriam
dc.contributor.authorMartins da Silva, Vanessa
dc.contributor.authorBarreiro, Alicia
dc.contributor.authorPuig i Sardà, Susana
dc.contributor.authorCaptier, Malvehy J Guillaume
dc.contributor.authorJames, Isabelle
dc.contributor.authorDegardin, Nathalie
dc.contributor.authorCarrera Álvarez, Cristina
dc.contributor.authorMalvehy, J. (Josep)
dc.contributor.authorEtchevers, Heather C.
dc.contributor.authorPuig Butillé, Joan Anton
dc.date.accessioned2020-06-15T15:35:16Z
dc.date.available2021-04-23T05:10:24Z
dc.date.issued2020-04-23
dc.date.updated2020-06-15T10:52:05Z
dc.description.abstractCongenital melanocytic nevi (CMN) are cutaneous malformations whose prevalence is inversely correlated with projected adult size. CMN are caused by somatic mutations, but epidemiological studies suggest that germline genetic factors may influence CMN development. In CMN patients from the U.K., genetic variants in MC1R, such as p.V92M and loss-of-function variants, have been previously associated with larger CMN. We analyzed the association of MC1R variants with CMN characteristics in two distinct cohorts of medium-to-giant CMN patients from Spain (N = 113) and from France, Norway, Canada, and the United States (N = 53), similar at the clinical and phenotypical level except for the number of nevi per patient. We found that the p.V92M or loss-of-function MC1R variants either alone or in combination did not correlate with CMN size, in contrast to the U.K. CMN patients. An additional case-control analysis with 259 unaffected Spanish individuals showed a higher frequency of MC1R compound heterozygous or homozygous variant genotypes in Spanish CMN patients compared to the control population (15.9% vs. 9.3%; p = .075). Altogether, this study suggests that MC1R variants are not associated with CMN size in these non-UK cohorts. Additional studies are required to define the potential role of MC1R as a risk factor in CMN development.© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.ca
dc.format.mimetypeapplication/pdf
dc.identifier.idimarina6311618
dc.identifier.issn1755-148X
dc.identifier.urihttps://hdl.handle.net/2445/165617
dc.language.isoengca
dc.publisherWileyca
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1111/pcmr.12883
dc.relation.ispartofPigment Cell & Melanoma Research, 2020-NA
dc.relation.urihttps://doi.org/10.1111/pcmr.12883
dc.rights(c) John Wiley & Sons, 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
dc.subject.classificationFenotip
dc.subject.classificationMalalties de la pell
dc.subject.classificationPolimorfisme genètic
dc.subject.otherPhenotype
dc.subject.otherSkin diseases
dc.subject.otherGenetic polymorphisms
dc.titleMelanocortin-1 receptor (MC1R) genotypes do not correlate with size in two cohorts of medium-to-giant congenital melanocytic nevica
dc.typeinfo:eu-repo/semantics/articleca

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
12474_6311618_mc1r_genotypes_do_not_correlate_with_size_in_two_cohorts_of_medium-to-giant_cmn.pdf
Mida:
562.74 KB
Format:
Adobe Portable Document Format